Oral Corticosteroid Burden (PDF)
22 March 2022View
In a single year one quarter of people with asthma have cumulative exposure to oral corticosteroid levels associated with long term toxicity.
Airflow Limitation (PDF)
27 January 2022View
Airflow limitation means that the flow of air through the airways is impaired. The presence, level and severity of airflow limitation can be different for people with asthma and chronic obstructive pulmonary disease.
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
30 September 2021View
Oral corticosteroids (OCS) are an effective treatment for acute and chronic severe asthma. However the indiscriminate use of OCS poses a risk of serious side effects and irreversible harm. There is an urgent need to introduce OCS stewardship approaches.
Airway Disease Heterogeneity (PDF)
16 September 2021View
Not all asthma or COPD are the same. These conditions are complex and heterogeneous in terms of their associated traits and comorbidities. Learn more using our infographic below.
What is Multidimensional Assessment? (PDF)
1 September 2021View
Multidimensional assessment is a systematic assessment of a patient’s symptoms and comorbidities. Learn more using our infographic below.
What is Treatable Traits? (PDF)
28 April 2021View
Treatable Traits is a model of care designed to address the heterogeneity of chronic airway diseases, such as COPD and asthma. Learn more using our infographic below.